MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Hemoglobin Levels and Non Motor Symptoms in Parkinsons Disease Patients with Modified Hoehn and Yahr Scores

    F. Hukmiyya, E. Pasmanasari, A. Wati, S. Santoso (Semarang, Indonesia)

    Objective: This study aims to explore the association between hemoglobin (Hb) levels and the severity of non motor symptoms in Parkinson’s disease as evaluated through…
  • 2026 International Congress

    The Historical Role of Sex and Gender in the History of Access to Movement Disorder Care: A Literature Review

    S. Corrick, J. Miyasaki, F. Ba, S. Joza (Edmonton, Canada)

    Objective: This literature review provides an overview of historical factors rooted in gender roles and institutional biases that have contributed to disparities in movement disorder…
  • 2026 International Congress

    Five‑Year Outcomes Following Unilateral MR‑Guided Focused Ultrasound Pallidotomy in Parkinson’s Disease

    A. Fasano, A. Sokolov, K. Gant, A. Grinspan (Toronto, Canada)

    Objective: To evaluate 5-year outcomes following unilateral GPi MRgFUS. Background: MR‑guided focused ultrasound (MRgFUS) of the internal segment of globus pallidus internus (GPi) is an…
  • 2026 International Congress

    Therapeutic effects of intermittent theta-burst stimulation on motor, non-motor symptoms and functional connectivity in de novo Parkinson’s disease

    R. Rashid-López, P. Macías-García, AJ. Cruz-Gómez, FL. Sánchez-Fernández, E. Sarrias-Arrabal, F. Cano-Cano, M. García-Corrales, R. Martínez-Regueiro, M. Melcón-Martín, F. Sanmartino, R. Espinosa-Rosso, JJ. González-Rosa (Cádiz, Spain)

    Objective: To evaluate the clinical and resting-state functional connectivity effects of bilateral M1-iTBS in patients with de novo Parkinson’s disease. Background: Dopaminergic neurodegeneration in Parkinson’s…
  • 2026 International Congress

    Evaluating Gene-Environment Interactions between Head Injury and Parkinson’s Disease Risk Variants.

    A. Kuri, S. Waters, L. Jones, N. Del Rey, L. Screven, H. Iwaki, M. Nalls, A. Noyce (London, United Kingdom)

    Objective: To evaluate gene-environment interactions between head injury and candidate single nucleotide polymorphisms (SNP) in Parkinson’s disease (PD). Background: Head injury is consistently associated with…
  • 2026 International Congress

    Bayesian Network Analysis of Directional Relationships Among Motor and Non-Motor Symptoms in Parkinson’s Disease

    A. Al-Sharman, H. Khalil, D. Malouche, S. Kanaan, M. Kim, N. Saad, M. Abdelrazeq (Sharjah, United Arab Emirates)

    Objective: To identify directional relationships among motor and non-motor symptoms in people with Parkinson’s disease (PD) using Bayesian Network analysis and to identify central variables…
  • 2026 International Congress

    Gait Kinematics as Biomarkers of Preclinical Parkinson’s Disease: A Systematic Review of Sensor-Based Studies

    K. Makhoul, N. Elayan, K. Fisher, R. Ramdhani (New York, USA)

    Objective: To systematically review existing literature on gait kinematics in individuals at increased risk for Parkinson’s disease (PD) and evaluate the role of sensor-based kinematic…
  • 2026 International Congress

    Deep Brain Stimulation Outcomes in Parkinson’s Disease Patients With GBA1 Variants: A Systematic Review and Meta-analysis

    A. Hegazi, R. Mohamed, H. Hussein (Mansoura, Egypt)

    Objective: To compare motor, cognitive, and medication outcomes following deep brain stimulation (DBS) in Parkinson’s disease patients with GBA1 variants versus non-carriers Background: Variants in…
  • 2026 International Congress

    Differences in Levodopa Equivalent Daily Dose (LEDD) Based on Disease Duration in Parkinson’s Disease Patients at RSCM – A Tertiary National Referral Hospital

    F. Abdat, A. Tiksnadi, D. Tungjungsari (Jakarta, Indonesia)

    Objective: This study aimed to evaluate differences in LEDD among Parkinson's disease (PD) patients based on disease duration categories from onset at RSCM Neurology Outpatient…
  • 2026 International Congress

    Various Levodopa Formulation effects on Local Field Potentials in Parkinson’s Disease

    A. Madamangalam, J. Cagle, C. de Hemptinne, J. Wong (Gainesville, USA)

    Objective: To describe the electrophysiological changes that occur in the brain with the use of foscarbidopa-foslevodopa and compare it to other common formulations of levodopa…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley